European Cystic Fibrosis Society Clinical Trial Network, Queens University Belfast
Dr Kathryn Hill is currently Research Manager for the European Cystic Fibrosis Society Clinical Trials Network (ECFS CTN), based at the Wellcome Wolfson Institute for Experimental Medicine at Queen's University, Belfast. Prior to this, Dr Hill held a post-doctoral research post in physiotherapy at Ulster University. She completed her BSc (Hons) Degree in Physiotherapy at Ulster University in 2011, following a BSc and PhD at Queen's University in 1994. She joined the ECFS CTN and Queen's University in 2015.
Dr Hill's research portfolio is focused on respiratory health, with a specific interest in cystic fibrosis (CF). She is coordinator of multiple working groups within the ECFS CTN, exploring lung imaging in CF, patient reported outcome measures (PROMs) with the ECFS CTN and CF Europe PROMs Special Interest Group, working to develop patient-led outcome measures in the field of CF, alongside coordination of working groups on CF diagnostic techniques, inflammatory biomarkers in CF, anthropometrics, microbiological techniques, and respiratory function measurement.
These projects are funded for example by both the ECFS, and the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN) and include international, multi-centre trials, employing a wide range of trial designs (RCTs and observational studies) and both quantitative and qualitative methodologies.
Dr Hill is currently co-applicant on a Gregory Lemarchal Association funded observational study in France and Belgium to assess patient reported outcome measures in CF, within this trial she co-leads on the validation of a new PROMs tool to assess the impact of cystic fibrosis transmembrane conductance regulator (CFTR) therapies on quality of life and symptom report in people with CF.
Thursday, September 26, 2024
1:30 PM – 2:20 PM ET